IDH1 and glioma: However, a comparison of combined IDH1R132H mutant and IDH1-immunonegative low grade gliomas (grade II astrocytoma, oligodendrogliomas, and mixed oligoastrocytomas) also failed to demonstrate a significant difference (p = 0.21).